dostarlimab
fujifilm diosynth biotechnologies,gsk
['rectal', 'dostarlimab', 'atara']
exciting results for n=12 patients studied with mismatch repair deficient, locally advanced rectal cancer given an anti-pd-1 mab (dostarlimab) x 6mo. all 12 with a sustained complete clinical response at 12mo. #asco22 
Dir of Prev Cardiology @MassGeneralNews | Assoc Prof @harvardmed | Assoc Mem @broadinstitute | Assoc Ed @JAMACardio @ScienceAdvances | Co-Founder @tensixteenbio